The Senate last night voted 98-2 to approve the Patient Right to Know Drug Prices Act (S. 2554), a bill that would prohibit private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance. Some health insurance contracts prevent pharmacists from informing patients when the cash price for their prescription costs less than their insurance cost-sharing arrangement unless the individual asks. The Senate earlier this month passed a similar bill that applies to patients in Medicare Advantage and Medicare Part D plans. The House Energy and Commerce Committee last week approved similar legislation for Medicare and private health plans.

Related News Articles

Headline
The House Energy and Commerce Committee today advanced by a 30-24 vote along party lines its portion of the fiscal year 2025 reconciliation bill following a…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 14 testified on President Trump’s discretionary budget proposal for fiscal year…
Headline
The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours…
Headline
The House Energy and Commerce Committee late on May 11 released legislative text in advance of the May 13 markup on its portion of the reconciliation bill.…
Headline
The House committees with jurisdiction over Medicaid and other health care programs have announced they will begin marking up their portions of the budget…
Headline
The AHA May 8 voiced support for the Save Healthcare Workers Act to House and Senate sponsors of the legislation. The bipartisan bill would make it a federal…